Injection Influenza Vaccine Market Size, Share, Growth, and Industry Analysis, By Types (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), By Applications Covered (6 Months to 3 Years, > 3 Years), Regional Insights and Forecast to 2033

Detailed TOC of Global Injection Influenza Vaccine Market Research Report 2025

1 Injection Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Injection Influenza Vaccine
1.2 Injection Influenza Vaccine Segment by Type
1.2.1 Global Injection Influenza Vaccine Market Value Comparison by Type (2025-2033)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Injection Influenza Vaccine Segment by Application
1.3.1 Global Injection Influenza Vaccine Market Value by Application: (2025-2033)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Injection Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Injection Influenza Vaccine Revenue 2018-2033
1.4.2 Global Injection Influenza Vaccine Sales 2018-2033
1.4.3 Global Injection Influenza Vaccine Market Average Price (2018-2033)
1.5 Assumptions and Limitations
2 Injection Influenza Vaccine Market Competition by Manufacturers
2.1 Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2018-2025)
2.2 Global Injection Influenza Vaccine Revenue Market Share by Manufacturers (2018-2025)
2.3 Global Injection Influenza Vaccine Average Price by Manufacturers (2018-2025)
2.4 Global Injection Influenza Vaccine Industry Ranking 2021 VS 2025 VS 2025
2.5 Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injection Influenza Vaccine, Product Type & Application
2.7 Injection Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Injection Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injection Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injection Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Injection Influenza Vaccine Market Size by Region: 2018 Versus 2025 Versus 2033
3.2 Global Injection Influenza Vaccine Global Injection Influenza Vaccine Sales by Region: 2018-2033
3.2.1 Global Injection Influenza Vaccine Sales by Region: 2018-2025
3.2.2 Global Injection Influenza Vaccine Sales by Region: 2024-2033
3.3 Global Injection Influenza Vaccine Global Injection Influenza Vaccine Revenue by Region: 2018-2033
3.3.1 Global Injection Influenza Vaccine Revenue by Region: 2018-2025
3.3.2 Global Injection Influenza Vaccine Revenue by Region: 2024-2033
3.4 North America Injection Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Injection Influenza Vaccine Market Size by Country: 2018 VS 2025 VS 2033
3.4.2 North America Injection Influenza Vaccine Sales by Country (2018-2033)
3.4.3 North America Injection Influenza Vaccine Revenue by Country (2018-2033)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injection Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Injection Influenza Vaccine Market Size by Country: 2018 VS 2025 VS 2033
3.5.2 Europe Injection Influenza Vaccine Sales by Country (2018-2033)
3.5.3 Europe Injection Influenza Vaccine Revenue by Country (2018-2033)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injection Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Injection Influenza Vaccine Market Size by Country: 2018 VS 2025 VS 2033
3.6.2 Asia Pacific Injection Influenza Vaccine Sales by Country (2018-2033)
3.6.3 Asia Pacific Injection Influenza Vaccine Revenue by Country (2018-2033)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injection Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Injection Influenza Vaccine Market Size by Country: 2018 VS 2025 VS 2033
3.7.2 Latin America Injection Influenza Vaccine Sales by Country (2018-2033)
3.7.3 Latin America Injection Influenza Vaccine Revenue by Country (2018-2033)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injection Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Injection Influenza Vaccine Market Size by Country: 2018 VS 2025 VS 2033
3.8.2 Middle East and Africa Injection Influenza Vaccine Sales by Country (2018-2033)
3.8.3 Middle East and Africa Injection Influenza Vaccine Revenue by Country (2018-2033)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injection Influenza Vaccine Sales by Type (2018-2033)
4.1.1 Global Injection Influenza Vaccine Sales by Type (2018-2025)
4.1.2 Global Injection Influenza Vaccine Sales by Type (2024-2033)
4.1.3 Global Injection Influenza Vaccine Sales Market Share by Type (2018-2033)
4.2 Global Injection Influenza Vaccine Revenue by Type (2018-2033)
4.2.1 Global Injection Influenza Vaccine Revenue by Type (2018-2025)
4.2.2 Global Injection Influenza Vaccine Revenue by Type (2024-2033)
4.2.3 Global Injection Influenza Vaccine Revenue Market Share by Type (2018-2033)
4.3 Global Injection Influenza Vaccine Price by Type (2018-2033)
5 Segment by Application
5.1 Global Injection Influenza Vaccine Sales by Application (2018-2033)
5.1.1 Global Injection Influenza Vaccine Sales by Application (2018-2025)
5.1.2 Global Injection Influenza Vaccine Sales by Application (2024-2033)
5.1.3 Global Injection Influenza Vaccine Sales Market Share by Application (2018-2033)
5.2 Global Injection Influenza Vaccine Revenue by Application (2018-2033)
5.2.1 Global Injection Influenza Vaccine Revenue by Application (2018-2025)
5.2.2 Global Injection Influenza Vaccine Revenue by Application (2024-2033)
5.2.3 Global Injection Influenza Vaccine Revenue Market Share by Application (2018-2033)
5.3 Global Injection Influenza Vaccine Price by Application (2018-2033)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2025)
6.1.4 Sanofi Injection Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2025)
6.2.4 CSL Injection Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2025)
6.3.4 GSK Injection Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2025)
6.4.4 Viatris Injection Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2025)
6.5.4 AstraZeneca Injection Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2025)
6.6.4 Hualan Bio Injection Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2025)
6.4.4 Changchun Institute of Biological Injection Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2025)
6.8.4 Sinovac Injection Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 Jiangsu GDK
6.9.1 Jiangsu GDK Corporation Information
6.9.2 Jiangsu GDK Description and Business Overview
6.9.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2025)
6.9.4 Jiangsu GDK Injection Influenza Vaccine Product Portfolio
6.9.5 Jiangsu GDK Recent Developments/Updates
6.10 KM Biologics
6.10.1 KM Biologics Corporation Information
6.10.2 KM Biologics Description and Business Overview
6.10.3 KM Biologics Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2025)
6.10.4 KM Biologics Injection Influenza Vaccine Product Portfolio
6.10.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injection Influenza Vaccine Industry Chain Analysis
7.2 Injection Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injection Influenza Vaccine Production Mode & Process
7.4 Injection Influenza Vaccine Sales and Marketing
7.4.1 Injection Influenza Vaccine Sales Channels
7.4.2 Injection Influenza Vaccine Distributors
7.5 Injection Influenza Vaccine Customers
8 Injection Influenza Vaccine Market Dynamics
8.1 Injection Influenza Vaccine Industry Trends
8.2 Injection Influenza Vaccine Market Drivers
8.3 Injection Influenza Vaccine Market Challenges
8.4 Injection Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer